India is rapidly transforming into one of the world’s most attractive destinations for clinical research and drug development. With a population exceeding 1.4 billion, a diverse genetic pool, highly qualified investigators, cost-efficient operations, and a progressively evolving regulatory environment, India is increasingly being recognized as a strategic hub for global clinical trials. The India clinical trials […]